Test Price
2,800 AED✅ Home Collection Available
EPG5 Gene Vici Syndrome Genetic Test in UAE | 2800 AED | DHA Approved
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Post-test telephonic result interpretation by DHA-licensed clinicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 before sample collection.
Test Overview & Methodology
The EPG5 Gene Vici Syndrome Genetic Test is a high‑precision single‑gene sequencing analysis using Next Generation Sequencing (NGS) technology, designed to detect pathogenic mutations in the EPG5 gene responsible for Vici syndrome—a rare autosomal recessive multisystem disorder affecting the nervous system, eyes, heart, and immune system. The test provides definitive molecular diagnosis when clinical signs such as agenesis of corpus callosum, cataracts, and cardiomyopathy are present.
| Feature | Our Test (EPG5 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity, full gene coverage | Limited to targeted regions; ~95% sensitivity |
| Methodology | NGS with deep bioinformatics pipelines | Sanger Sequencing, single variant focus |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403 notes: “This genetic test provides a definitive molecular diagnosis for Vici syndrome, but results must be correlated with clinical findings and family history. I never recommend making life-changing decisions based solely on a lab report; always consult with a multidisciplinary team including a pediatric neurologist and clinical geneticist. Your child's health is a mosaic—let’s interpret each piece together.”
Advisory Warning
Genetic test results should be interpreted in the context of complete clinical evaluation. Do not use this test as a sole basis for treatment decisions. Always seek guidance from a qualified healthcare professional before making any changes to medication or therapy.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inadequate sample (hemolyzed blood, insufficient volume), contaminated FTA card, or missing informed consent. For minors, legal guardian consent is mandatory per Federal Decree-Law No. 4 of 2016.
- Emergency Red Flags: If the detected mutation is associated with severe cardiomyopathy or immune deficiency, urgent referral to pediatric cardiology/immunology is required. Seek immediate medical attention if the child experiences sudden breathing difficulty, cyanosis, or seizures—do not wait for genetic results.
Patient FAQ & Clinical Guidance
1. How accurate is the EPG5 NGS test for diagnosing Vici syndrome in infants?
Snippet Answer: Our EPG5 NGS test achieves 99.9% diagnostic sensitivity using deep sequencing and rigorous bioinformatics, covering the entire coding region of the EPG5 gene. It is performed in an ISO 9001:2015 accredited facility, making it the gold standard for confirming Vici syndrome when clinical signs are present.
2. What sample types are accepted and how is home collection arranged in UAE?
Snippet Answer: Acceptable samples include peripheral whole blood, extracted DNA, or one drop on an FTA card. Our VIP Mobile Phlebotomy team provides hospital-grade home collection daily from 8 AM to 11 PM with temperature-controlled cold-chain transport. To book, WhatsApp +971 54 548 8731; we verify insurance and ensure compliance with UAE PDPL.
3. Will insurance cover this genetic test in the UAE?
Snippet Answer: Most major UAE insurers cover the EPG5 NGS test when prescribed by a pediatrician or clinical geneticist. We provide direct billing verification via WhatsApp at +971 54 548 8731 before the procedure. Coverage is subject to policy limits; self-pay options are available at 2800 AED.
UAE Regulatory & Data Privacy Adherence
Compliance Statement: This test adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is handled with strict confidentiality and stored in ISO-certified secure systems.
Clinical & Logistical Metadata
| Test Name | EPG5 Gene Vici Syndrome Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or FTA card |
| Methodology Used | Next Generation Sequencing (NGS) with full EPG5 gene coverage |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 94497-5 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians